By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Glide Pharma 

45B Milton Park

Abingdon  Oxfordshire  OX14 4RU  United Kingdom
Phone: 44-0-8700-853700 Fax: 44-0-8700-853704



Company News
Glide Pharma Takes Exclusive Worldwide Rights To Novel Diagnostic Technology For Prostate Cancer 7/29/2014 7:53:32 AM
Glide Pharma Completes Successful Proof-Of-Concept Study With Novel Solid Dose Formulation Of Octreotide 7/22/2014 7:14:10 AM
Glide Pharma Appoints Richard Bungay As Chief Financial Officer And Tony Mills As Director Of Business Development 7/8/2014 9:11:58 AM
Glide Pharma Appoints Bryan G Morton as Chairman and Announces Board Changes 10/9/2013 9:39:15 AM
Glide Pharma Announces Design Optimisation Agreement With Nypro Healthcare for Scale Up of Solid Dose Delivery Device 7/2/2013 9:38:01 AM
Pfenex Inc. Awards Glide Pharma Development Contract for a Solid Formulation of Recombinant Anthrax Vaccine 4/30/2013 10:21:06 AM
Glide Pharma Appoints Dr Mark Carnegie-Brown as Chief Executive 3/6/2013 1:40:34 PM
Glide Pharma Announces Completion of $21.4 Million Investment 2/26/2013 7:15:10 AM
Glide Pharma Announces £2.3 Million ($3.7 Million) Award From UK Biomedical Catalyst for Development of Osteoporosis Treatment 11/5/2012 12:06:10 PM
Glide Pharma Completes Oversubscribed $4.3 Million Investment Round 2/10/2010 7:09:58 AM